div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: Infliximab trough levels may predict sustained response to infliximab in patients with Crohns disease src=https:reader030vdocumentinreader030viewer2022021217577ce40f1a28abf1038d9b93html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divp pdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: Infliximab trough levels may predict sustained response to infliximab in patients with Crohns disease src=https:reader030vdocumentinreader030viewer2022021217577ce40f1a28abf1038d9b93html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divp pdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: Infliximab trough levels may predict sustained response to infliximab in patients with Crohns disease src=https:reader030vdocumentinreader030viewer2022021217577ce40f1a28abf1038d9b93html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divp pdiv